Poland - Nowy Sącz: Antineoplastic and immunomodulating agents

Release

ID: ocds-pyfy63:2022-426732:2022-563530
Buyer: Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym Sączu
Date: 2022-10-14
Language: PL
Tags: award

Release in JSON

Process

ID (OCID): ocds-pyfy63:2022-426732
Releases: 2022-08-05 (ocds-pyfy63:2022-426732:2022-426732)
2022-10-14 (ocds-pyfy63:2022-426732:2022-563530)
2023-07-07 (ocds-pyfy63:2022-426732:2023-409670)
2023-07-07 (ocds-pyfy63:2022-426732:2023-413170)

Releases in JSON

Tender

Title: Poland - Nowy Sącz: Antineoplastic and immunomodulating agents
Award criteria: priceOnly
Award criteria details: Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price

Award criteria for item 40:
- Price

Award criteria for item 41:
- Price

Award criteria for item 42:
- Price

Award criteria for item 43:
- Price

Award criteria for item 44:
- Price

Award criteria for item 45:
- Price

Award criteria for item 46:
- Price

Award criteria for item 47:
- Price

Award criteria for item 48:
- Price

Award criteria for item 49:
- Price

Award criteria for item 50:
- Price

Award criteria for item 51:
- Price

Award criteria for item 52:
- Price

Award criteria for item 53:
- Price

Award criteria for item 54:
- Price

Award criteria for item 55:
- Price

Award criteria for item 56:
- Price

Award criteria for item 57:
- Price

Award criteria for item 58:
- Price

Award criteria for item 59:
- Price

Award criteria for item 60:
- Price

Award criteria for item 61:
- Price

Award criteria for item 62:
- Price

Award criteria for item 63:
- Price

Award criteria for item 64:
- Price
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure
Tender period: 2022-10-14 - ?
Tenderers: Urtica Sp. z o.o.
Amgen Sp. z o.o.
Sanofi-Aventis Sp. z o.o.,
Servier Polska Services Sp. z o.o.
Pfizer Trading Polska Sp. z o.o. ul. Żwirki i Wigury 16B 02-092
Astra Zeneca Kft. 1117
Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613
Roche Polska Sp. z o.o.
Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672
Farmacol Logistyka Sp. z o.o.
Takeda Pharma Sp. z o.o.
Astra Zeneca Kft.
Pfizer Trading Polska Sp. z o.o.
Farmacol Logistyka Sp. z o.o.
Roche Polska Sp. z o.o.
Urtica Sp. z o.o.
Astra Zeneca Kft.
Komtur Polska Sp. z o.o.
Janssen-Cilag Polska Sp. z o.o
Astellas Pharma Sp. z o.o.
Asclepios SA.
Komtur Polska Sp. z o.o.
Abbvie Sp. z o.o.
Farmacol Logistyka Sp. z o.o
Salus International Sp. z o.o., 40-273 ul. Pułaskiego 9
Roche Polska Sp. z o.o. u
Centrala Farmaceutyczna CEFARM SA
Sanofi-Aventis Sp. z o.o.
CSL Behring Sp. z o.o. ul. A. Branickiego 17, 02-972
GSK Services Sp. z o.o.
Janssen-Cilag Polska Sp. z o.o ul. Iłżecka 24, 02-135

Tender item

ID: ocds-pyfy63:2022-426732:obj:1
Classification: CPV / 33652000
Description: Cetuksymab

Tender item

ID: ocds-pyfy63:2022-426732:obj:2
Classification: CPV / 33652000
Description: Panitumumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:3
Classification: CPV / 33652000
Description: Aflibercep

Tender item

ID: ocds-pyfy63:2022-426732:obj:4
Classification: CPV / 33652000
Description: Triflurydyna + Typiracyl

Tender item

ID: ocds-pyfy63:2022-426732:obj:5
Classification: CPV / 33652000
Description: Kryzotynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:6
Classification: CPV / 33652000
Description: Ozymertynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:7
Classification: CPV / 33652000
Description: Niwolumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:8
Classification: CPV / 33652000
Description: Pembrolizumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:9
Classification: CPV / 33652000
Description: Atezolizumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:10
Classification: CPV / 33652000
Description: Afatynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:11
Classification: CPV / 33652000
Description: Nintedanib

Tender item

ID: ocds-pyfy63:2022-426732:obj:12
Classification: CPV / 33652000
Description: Alektynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:13
Classification: CPV / 33652000
Description: Cerytynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:14
Classification: CPV / 33652000
Description: Brygatynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:15
Classification: CPV / 33652000
Description: Durwalumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:16
Classification: CPV / 33652000
Description: Dakomitynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:17
Classification: CPV / 33652000
Description: Lorlatynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:18
Classification: CPV / 33652000
Description: Trastuzumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:19
Classification: CPV / 33652000
Description: Trastuzumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:20
Classification: CPV / 33652000
Description: Lapatynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:21
Classification: CPV / 33652000
Description: Pertuzumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:22
Classification: CPV / 33652000
Description: Palbocyklib

Tender item

ID: ocds-pyfy63:2022-426732:obj:23
Classification: CPV / 33652000
Description: Rybocyklib

Tender item

ID: ocds-pyfy63:2022-426732:obj:24
Classification: CPV / 33652000
Description: Trastuzumab emtanzyna

Tender item

ID: ocds-pyfy63:2022-426732:obj:25
Classification: CPV / 33652000
Description: Abemacyklib

Tender item

ID: ocds-pyfy63:2022-426732:obj:26
Classification: CPV / 33652000
Description: Obinutuzumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:27
Classification: CPV / 33652000
Description: Olaparyb

Tender item

ID: ocds-pyfy63:2022-426732:obj:28
Classification: CPV / 33652000
Description: Lenalidomid

Tender item

ID: ocds-pyfy63:2022-426732:obj:29
Classification: CPV / 33652000
Description: Pomalidomid

Tender item

ID: ocds-pyfy63:2022-426732:obj:30
Classification: CPV / 33652000
Description: Daratumumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:31
Classification: CPV / 33652000
Description: Karfilzomib

Tender item

ID: ocds-pyfy63:2022-426732:obj:32
Classification: CPV / 33652000
Description: Iksazomib

Tender item

ID: ocds-pyfy63:2022-426732:obj:33
Classification: CPV / 33652000
Description: Octan abirateronu

Tender item

ID: ocds-pyfy63:2022-426732:obj:34
Classification: CPV / 33652000
Description: Enzalutamid

Tender item

ID: ocds-pyfy63:2022-426732:obj:35
Classification: CPV / 33652000
Description: Dazatynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:36
Classification: CPV / 33652000
Description: Blinatumomab

Tender item

ID: ocds-pyfy63:2022-426732:obj:37
Classification: CPV / 33652000
Description: Ponatynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:38
Classification: CPV / 33652000
Description: Inotuzumab ozogamycyny

Tender item

ID: ocds-pyfy63:2022-426732:obj:39
Classification: CPV / 33652000
Description: Brentuxymab vedotin

Tender item

ID: ocds-pyfy63:2022-426732:obj:40
Classification: CPV / 33652000
Description: Ruksolitynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:41
Classification: CPV / 33652000
Description: Paklitaksel z albuminą

Tender item

ID: ocds-pyfy63:2022-426732:obj:42
Classification: CPV / 33652000
Description: Ibrutynib

Tender item

ID: ocds-pyfy63:2022-426732:obj:43
Classification: CPV / 33652000
Description: Piksantronu dimaleinian

Tender item

ID: ocds-pyfy63:2022-426732:obj:44
Classification: CPV / 33652000
Description: Eltrombopag

Tender item

ID: ocds-pyfy63:2022-426732:obj:45
Classification: CPV / 33652000
Description: Romiplostym

Tender item

ID: ocds-pyfy63:2022-426732:obj:46
Classification: CPV / 33652000
Description: Wenetoklaks

Tender item

ID: ocds-pyfy63:2022-426732:obj:47
Classification: CPV / 33652000
Description: Midostauryna

Tender item

ID: ocds-pyfy63:2022-426732:obj:48
Classification: CPV / 33652000
Description: Interferon β-1a

Tender item

ID: ocds-pyfy63:2022-426732:obj:49
Classification: CPV / 33652000
Description: Fumaran dimetylu

Tender item

ID: ocds-pyfy63:2022-426732:obj:50
Classification: CPV / 33652000
Description: Peginterferon-β-1a

Tender item

ID: ocds-pyfy63:2022-426732:obj:51
Classification: CPV / 33652000
Description: Teryflunomid

Tender item

ID: ocds-pyfy63:2022-426732:obj:52
Classification: CPV / 33652000
Description: Fingolimod

Tender item

ID: ocds-pyfy63:2022-426732:obj:53
Classification: CPV / 33652000
Description: Natalizumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:54
Classification: CPV / 33652000
Description: Okrelizumab

Tender item

ID: ocds-pyfy63:2022-426732:obj:55
Classification: CPV / 33652000
Description: Kladrybina

Tender item

ID: ocds-pyfy63:2022-426732:obj:56
Classification: CPV / 33652000
Description: Alemtuzumabum

Tender item

ID: ocds-pyfy63:2022-426732:obj:57
Classification: CPV / 33652000
Description: Interferon β- 1a

Tender item

ID: ocds-pyfy63:2022-426732:obj:58
Classification: CPV / 33652000
Description: Interferon β- 1b

Tender item

ID: ocds-pyfy63:2022-426732:obj:59
Classification: CPV / 33652000
Description: Immunoglobuliny

Tender item

ID: ocds-pyfy63:2022-426732:obj:60
Classification: CPV / 33652000
Description: Niraparyb

Tender item

ID: ocds-pyfy63:2022-426732:obj:61
Classification: CPV / 33652000
Description: Apalutamid

Tender item

ID: ocds-pyfy63:2022-426732:obj:62
Classification: CPV / 33652000
Description: Darolutamid

Tender item

ID: ocds-pyfy63:2022-426732:obj:63
Classification: CPV / 33652000
Description: Polatuzumab wedotyny

Tender item

ID: ocds-pyfy63:2022-426732:obj:64
Classification: CPV / 33652000
Description: Fedratynib

Award

ID: ocds-pyfy63:2022-426732:award:0
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:1
Status: active
Suppliers: Amgen Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:2
Status: active
Suppliers: Sanofi-Aventis Sp. z o.o.,

Award

ID: ocds-pyfy63:2022-426732:award:3
Status: active
Suppliers: Servier Polska Services Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:4
Status: active
Suppliers: Pfizer Trading Polska Sp. z o.o. ul. Żwirki i Wigury 16B 02-092

Award

ID: ocds-pyfy63:2022-426732:award:5
Status: active
Suppliers: Astra Zeneca Kft. 1117

Award

ID: ocds-pyfy63:2022-426732:award:6
Status: active
Suppliers: Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613

Award

ID: ocds-pyfy63:2022-426732:award:7
Status: active
Suppliers: Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613

Award

ID: ocds-pyfy63:2022-426732:award:8
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:9
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:10
Status: active
Suppliers: Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613

Award

ID: ocds-pyfy63:2022-426732:award:11
Status: active
Suppliers: Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672

Award

ID: ocds-pyfy63:2022-426732:award:12
Status: active
Suppliers: Farmacol Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:13
Status: active
Suppliers: Takeda Pharma Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:14
Status: active
Suppliers: Astra Zeneca Kft.

Award

ID: ocds-pyfy63:2022-426732:award:15
Status: active
Suppliers: Pfizer Trading Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:16
Status: active
Suppliers: Pfizer Trading Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:17
Status: active
Suppliers: Farmacol Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:18
Status: active
Suppliers: Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672

Award

ID: ocds-pyfy63:2022-426732:award:19
Status: active
Suppliers: Farmacol Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:20
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:21
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:22
Status: active
Suppliers: Farmacol Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:23
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:24
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:25
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:26
Status: active
Suppliers: Astra Zeneca Kft.

Award

ID: ocds-pyfy63:2022-426732:award:27
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:28
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:29
Status: active
Suppliers: Janssen-Cilag Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-426732:award:30
Status: active
Suppliers: Amgen Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:31
Status: active
Suppliers: Takeda Pharma Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:32
Status: active
Suppliers: Janssen-Cilag Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-426732:award:33
Status: active
Suppliers: Astellas Pharma Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:34
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:35
Status: active
Suppliers: Amgen Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:36
Status: active
Suppliers: Asclepios SA.

Award

ID: ocds-pyfy63:2022-426732:award:37
Status: active
Suppliers: Pfizer Trading Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:38
Status: active
Suppliers: Takeda Pharma Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:39
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:40
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:41
Status: active
Suppliers: Janssen-Cilag Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-426732:award:42
Status: active
Suppliers: Servier Polska Services Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:43
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:44
Status: active
Suppliers: Amgen Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:45
Status: active
Suppliers: Abbvie Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:46
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:47
Status: active
Suppliers: Farmacol Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:48
Status: active
Suppliers: Farmacol Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:49
Status: active
Suppliers: Farmacol Logistyka Sp. z o.o

Award

ID: ocds-pyfy63:2022-426732:award:50
Status: active
Suppliers: Sanofi-Aventis Sp. z o.o.,

Award

ID: ocds-pyfy63:2022-426732:award:51
Status: active
Suppliers: Salus International Sp. z o.o., 40-273 ul. Pułaskiego 9

Award

ID: ocds-pyfy63:2022-426732:award:52
Status: active
Suppliers: Farmacol Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:53
Status: active
Suppliers: Roche Polska Sp. z o.o. u

Award

ID: ocds-pyfy63:2022-426732:award:54
Status: active
Suppliers: Centrala Farmaceutyczna CEFARM SA

Award

ID: ocds-pyfy63:2022-426732:award:55
Status: active
Suppliers: Sanofi-Aventis Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:56
Status: active
Suppliers: Centrala Farmaceutyczna CEFARM SA

Award

ID: ocds-pyfy63:2022-426732:award:57
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:58
Status: active
Suppliers: CSL Behring Sp. z o.o. ul. A. Branickiego 17, 02-972

Award

ID: ocds-pyfy63:2022-426732:award:59
Status: active
Suppliers: GSK Services Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:60
Status: active
Suppliers: Janssen-Cilag Polska Sp. z o.o ul. Iłżecka 24, 02-135

Award

ID: ocds-pyfy63:2022-426732:award:61
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-426732:award:62
Status: active
Suppliers: Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672

Award

ID: ocds-pyfy63:2022-426732:award:63
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Parties

Roles: buyer
Organization name: Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym Sączu
Street address: ul. Młyńska 10
Locality: Nowy Sącz
Postal code: 33-300
Country: PL
Contact name: Ryszard Tobiasz
E-mail: zamowieniapubliczne@szpitalnowysacz.pl
Phone: +48 184436635
Fax: +48 184436635
Website: www.szpitalnowysacz.pl

Organization data Organization in JSON

Roles: supplier
tenderer
Organization name: Urtica Sp. z o.o.
Locality: Wrocław
Country: PL

Organization data Organization in JSON

Roles: supplier
tenderer
Organization name: Amgen Sp. z o.o.
Locality: Warszawa
Country: PL

Organization data Organization in JSON

Roles: supplier
tenderer
Organization name: Sanofi-Aventis Sp. z o.o.,
Locality: Warszawa
Country: PL

Organization data Organization in JSON

Roles: supplier
tenderer
Organization name: Servier Polska Services Sp. z o.o.
Locality: Warszawa
Country: PL

Organization data Organization in JSON

Roles: supplier
tenderer
Organization name: Pfizer Trading Polska Sp. z o.o. ul. Żwirki i Wigury 16B 02-092
Locality: Warszawa
Country: PL